Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
- First Posted Date
- 2012-10-16
- Last Posted Date
- 2018-09-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 561
- Registration Number
- NCT01707368
- Locations
- 🇩🇪
PD Dr. med. Rosenbach, Osnabrück, Niedersachsen, Germany
Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
- Conditions
- Interventions
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 41
- Registration Number
- NCT01703078
- Locations
- 🇦🇺
Dermatology Department, Woolloongabba, Queensland, Australia
Cromoglicate in Mastocytosis
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2013-03-07
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 7
- Registration Number
- NCT01701843
- Locations
- 🇩🇪
Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2012-05-30
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01607853
- Locations
- 🇫🇷
Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, France
Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2016-09-16
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 37
- Registration Number
- NCT01600222
- Locations
- 🇨🇦
Guildford Dermatology Specialists, Surrey, British Columbia, Canada
🇨🇦PerCuro Clinical Research, Victoria, British Columbia, Canada
🇨🇦Maritime Medical Research Center, Bathurst, New Brunswick, Canada
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
- Conditions
- Interventions
- First Posted Date
- 2012-05-16
- Last Posted Date
- 2016-05-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 463
- Registration Number
- NCT01600014
- Locations
- 🇨🇦
Skin Care Centre, Vancouver, British Columbia, Canada
🇦🇺St John of God Dermatology, Subiaco, Australia
🇨🇦Stratica Medical, Edmonton, Alberta, Canada
A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
- Conditions
- First Posted Date
- 2012-04-19
- Last Posted Date
- 2013-12-30
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01580488
- Locations
- 🇫🇷
Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) - Hôpital l'Archet 2, 151 route Saint-Antoine de Ginestière, Nice, France
Study on Thrombosis Therapy in German Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 76
- Registration Number
- NCT01559883
- Locations
- 🇩🇪
Prof. Dr. Axel Matzdorff, Saarbrücken, Saarland, Germany
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
- Conditions
- Interventions
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 961
- Registration Number
- NCT01555463
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
- Conditions
- Interventions
- First Posted Date
- 2012-03-01
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 367
- Registration Number
- NCT01541553
- Locations
- 🇺🇸
Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
🇺🇸Suzanne Bruce and Associates, P.A., Houston, Texas, United States
🇺🇸Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, United States